Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder

Clinical trial NCT00399763 · COMPLETED

Trial details

NCT number: NCT00399763
Sponsor: Denver Health and Hospital Authority
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Substance Abuse

Start date: 2005-09-01
Primary completion: 2008-02-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.